Berkshire vs. Occidental: Who Actually Won the $10 Billion Chemicals Deal?

Berkshire Hathaway (BRK.A, BRK.B) closed a $9.7 billion purchase of Occidental Petroleum's (OXY) chemicals business in late 2025, and Occidental is already putting the cash to work on its balance sheet.

Occidental directed $6.5 billion of the proceeds, roughly 67% of the sale price, toward debt paydown. That leaves about $3.2 billion of the deal value for other uses. The move strips leverage out of OXY and sharpens its profile as a pure upstream oil and gas producer just as energy prices are rising, per the source.

For Berkshire, the transaction adds a chemicals operation to a diversified portfolio built around a long-term investment horizon. The source frames the asset as reliable rather than high-growth, which fits a buy-and-hold posture rather than a catalyst-driven trade.

Interpretation: the structure reads as a clean swap of priorities. OXY gets balance sheet relief and operational focus; Berkshire gets steady cash-generating capacity. Neither side appears to have overpaid or undersold based on the stated objectives, though the source offers no valuation multiple to test that.

Chevron (CVX) is flagged in the classifier context as a related name, though the supplied article does not detail any direct involvement.